Juan M. Flores-Guzman

Tepatitlán De Morelos CP 47620
Tepatitlan De Morelos, JAL 47620, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Mitochondrial-Centered Biological Networks in Metabolic Disease: Toward Precision Mitochondrial Medicine.

Mitochondrial-Centered Biological Networks in Metabolic Disease: Toward Precision Mitochondrial Medicine.

Journal: International journal of molecular sciences

Published: June 15, 2026

Chemical and enantioselective GC-MS characterization of Minthostachys mollis (Benth.) Griseb. Essential oil from Peru and its acetylcholinesterase inhibitory activity.

Chemical and enantioselective GC-MS characterization of Minthostachys mollis (Benth.) Griseb. Essential oil from Peru and its acetylcholinesterase inhibitory activity.

Journal: Frontiers in pharmacology

Published: April 24, 2026

In Silico Identification of Dual-Action Compounds Targeting TLR2 and Streptococcus mutans Proteins for the Prevention of Early Childhood Caries.

In Silico Identification of Dual-Action Compounds Targeting TLR2 and Streptococcus mutans Proteins for the Prevention of Early Childhood Caries.

Journal: Dentistry journal

Published: March 25, 2026

IL-15, IL-18 and IL-21 Along the Stress-Smoking-Periodontal Health Axis: A Cross-Sectional Study in Mexican Adults.

IL-15, IL-18 and IL-21 Along the Stress-Smoking-Periodontal Health Axis: A Cross-Sectional Study in Mexican Adults.

Journal: Biomedicines

Published: November 03, 2025

Luteolin as a Multitarget Agent against Colorectal Cancer Explored Through Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations.

Luteolin as a Multitarget Agent against Colorectal Cancer Explored Through Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations.

Journal: Current computer-aided drug design

Published: October 23, 2025

Exploring the Therapeutic Potential of Ginger (Zingiber officinale) Against Type 2 Diabetes: A Bioinformatic Approach.

Exploring the Therapeutic Potential of Ginger (Zingiber officinale) Against Type 2 Diabetes: A Bioinformatic Approach.

Journal: Current topics in medicinal chemistry

Published: October 20, 2025

Investigating Alternative Treatments for Dyslipidemia Using Bioactive Compounds Derived from Kiwifruit (Actinidia chinensis): A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis.

Investigating Alternative Treatments for Dyslipidemia Using Bioactive Compounds Derived from Kiwifruit (Actinidia chinensis): A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis.

Journal: Current drug targets

Published: September 03, 2025

Author's Reply to the Comment on "Pain control and adverse effects of parecoxib after wisdom teeth surgery: a quantitative systematic review".

Author's Reply to the Comment on "Pain control and adverse effects of parecoxib after wisdom teeth surgery: a quantitative systematic review".

Journal: Oral and maxillofacial surgery

Published: July 23, 2025

Correction to: Pain control and adverse effects of parecoxib after wisdom teeth surgery: a quantitative systematic review.

Correction to: Pain control and adverse effects of parecoxib after wisdom teeth surgery: a quantitative systematic review.

Journal: Oral and maxillofacial surgery

Published: July 04, 2025

Association of IL32 Variant rs45499297 with Gingivitis and IL-32 Levels: A Cross-sectional Clinical-bioinformatics Study.

Association of IL32 Variant rs45499297 with Gingivitis and IL-32 Levels: A Cross-sectional Clinical-bioinformatics Study.

Journal: Recent advances in inflammation & allergy drug discovery

Published: June 26, 2025

Evaluating Multifactorial Contributors to Metabolic Syndrome in Western Mexico: The Role of Metabolic Age, Lifestyle, and IL32 rs45499297 Polymorphism.

Evaluating Multifactorial Contributors to Metabolic Syndrome in Western Mexico: The Role of Metabolic Age, Lifestyle, and IL32 rs45499297 Polymorphism.

Journal: Endocrine, metabolic & immune disorders drug targets

Published: June 24, 2025

Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation of Mucuna pruriens for Parkinson's Disease Treatment.

Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation of Mucuna pruriens for Parkinson's Disease Treatment.

Journal: Current drug targets

Published: June 12, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026